GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Net Cash per Share

Zentek (TSXV:ZEN) Net Cash per Share : C$0.03 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Zentek Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Zentek's Net Cash per Share for the quarter that ended in Dec. 2023 was C$0.03.

The historical rank and industry rank for Zentek's Net Cash per Share or its related term are showing as below:

TSXV:ZEN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 13.33   Med: 48.33   Max: 358
Current: 50.67

During the past 13 years, the highest Price-to-Net-Cash Ratio of Zentek was 358.00. The lowest was 13.33. And the median was 48.33.

TSXV:ZEN's Price-to-Net-Cash is ranked worse than
91.02% of 323 companies
in the Medical Devices & Instruments industry
Industry Median: 6.99 vs TSXV:ZEN: 50.67

Zentek Net Cash per Share Historical Data

The historical data trend for Zentek's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek Net Cash per Share Chart

Zentek Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - - 0.23 0.07

Zentek Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.07 0.08 0.05 0.03

Competitive Comparison of Zentek's Net Cash per Share

For the Medical Instruments & Supplies subindustry, Zentek's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentek's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Zentek's Price-to-Net-Cash falls into.



Zentek Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Zentek's Net Cash per Share for the fiscal year that ended in Mar. 2023 is calculated as

Net Cash per Share (A: Mar. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(10.357-2.905-0)/99.534
=0.07

Zentek's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(5.346-2.355-0)/100.86
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentek  (TSXV:ZEN) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Zentek Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Zentek's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentek (TSXV:ZEN) Business Description

Traded in Other Exchanges
Address
24 Corporate Ct, Guelph, ON, CAN, N1G 5G5
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
Executives
Francis Jacques Dubé Director

Zentek (TSXV:ZEN) Headlines

From GuruFocus

Top 5 4th Quarter Trades of HARVEST MANAGEMENT LLC

By GuruFocus Research GuruFocus Editor 02-18-2023

WESTFIELD CAPITAL MANAGEMENT CO LP Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-14-2022

SHAREHOLDER ALERT: Weiss Law Investigates Zendesk, Inc.

By PRNewswire PRNewswire 07-14-2022

Top 5 2nd Quarter Trades of Sylebra Capital Ltd

By GuruFocus Research GuruFocus Editor 08-17-2022

Top 5 3rd Quarter Trades of TIG Advisors, LLC

By GuruFocus Research GuruFocus Editor 11-15-2022

Zendesk Announces Date of Third Quarter 2022 Financial Results

By Business Wire Business Wire 10-20-2022

Top 5 2nd Quarter Trades of Jana Partners

By GuruFocus Research GuruFocus Editor 08-15-2022